Writing for Harvard Business Review, Georgetown University's Christine Porath and Cleveland Clinic's Adrienne Boissy share six research-backed ways to curb disruptive patient behavior—and ensure providers can offer the best possible level of care.
As colon cancer grows increasingly common among younger adults, U.S. Preventive Services Task Force (USPSTF) on Tuesday finalized guidance recommending that most Americans start getting screened for the disease at age 45—five years earlier than previously recommended.
As more countries consider "mixing and matching" two Covid-19 vaccine doses from different manufacturers, trials are underway to test whether the practice is effective, safe, and feasible. Here's what an early trial into combining the Pfizer/BioNTech and AstraZeneca vaccines has learned so far.
HHS' Health Resources and Services Administration on Monday sent letters to six drug makers warning that they could be fined if they don't discount drug prices for pharmacies participating in the 340B program, in today's bite-sized hospital and health industry news from the District of Columbia, Georgia, and Nevada.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.